What is the recommended dose adjustment of Avicaz (meloxicam) for a patient with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Avicaz Dosing and Renal Adjustment

Critical Error in Question Context

The question contains a significant error: Avicaz is NOT meloxicam. Avicaz is the brand name for ceftazidime-avibactam (an antibiotic combination), while meloxicam is an NSAID. The provided evidence exclusively addresses meloxicam, influenza antivirals, and other unrelated medications, but contains no information about Avicaz/ceftazidime-avibactam dosing.

Standard Avicaz Dosing (From General Medical Knowledge)

For patients with normal renal function (CrCl >50 mL/min), the standard Avicaz dose is 2.5 grams (2 grams ceftazidime + 0.5 grams avibactam) administered intravenously over 2 hours every 8 hours.

Renal Dose Adjustments for Avicaz

The dosing interval must be extended based on creatinine clearance, while maintaining appropriate individual doses to preserve concentration-dependent bacterial killing:

  • CrCl 31-50 mL/min: 1.25 grams (1 gram ceftazidime + 0.25 grams avibactam) IV every 8 hours
  • CrCl 16-30 mL/min: 0.94 grams (0.75 grams ceftazidime + 0.19 grams avibactam) IV every 12 hours
  • CrCl 6-15 mL/min: 0.94 grams (0.75 grams ceftazidime + 0.19 grams avibactam) IV every 24 hours
  • CrCl ≤5 mL/min (including hemodialysis): 0.94 grams (0.75 grams ceftazidime + 0.19 grams avibactam) IV every 48 hours

Hemodialysis Considerations

For patients on intermittent hemodialysis, administer Avicaz after each dialysis session, as both ceftazidime and avibactam are removed during dialysis (approximately 55% and 50% respectively removed during a 3-4 hour session).

CRRT Dosing

For continuous renal replacement therapy (CRRT), use 2.5 grams IV every 8 hours or 1.25 grams IV every 6 hours, with therapeutic drug monitoring recommended to ensure adequate exposure.

Common Pitfalls to Avoid

  • Do not confuse Avicaz with meloxicam - they are completely different medications with different indications and dosing requirements
  • Always administer post-dialysis to avoid premature drug removal and ensure adequate antimicrobial exposure
  • Reassess renal function regularly (every 2-3 days in critically ill patients) as changes in kidney function require prompt dose adjustments
  • Use actual body weight for dosing calculations unless the patient is morbidly obese, in which case adjusted body weight may be more appropriate
  • Infuse over 2 hours to optimize pharmacodynamic parameters and reduce infusion-related adverse effects

Monitoring Parameters

  • Monitor renal function at baseline and every 2-3 days during therapy
  • Assess for signs of neurotoxicity (confusion, seizures) particularly in patients with severe renal impairment
  • Monitor for hypersensitivity reactions, especially in patients with beta-lactam allergies
  • Consider therapeutic drug monitoring in critically ill patients or those with unstable renal function

Note: The evidence provided does not contain FDA labeling or guidelines for Avicaz. This response is based on general medical knowledge of ceftazidime-avibactam dosing. For definitive dosing recommendations, consult the current FDA-approved prescribing information for Avicaz.

Related Questions

Is it safe to take meloxicam (nonsteroidal anti-inflammatory drug (NSAID)) with mild impaired renal function (eGFR of 71)?
Is meloxicam safe to use in a patient with impaired renal function?
Can a patient with Chronic Kidney Disease (CKD) and a Glomerular Filtration Rate (GFR) of 53 take meloxicam (Mobic) 7.5mg daily?
Is it safe for a 75-year-old patient with impaired renal function to continue taking meloxicam (Nonsteroidal Anti-Inflammatory Drug (NSAID)) for chronic pain management, or should they switch to Tylenol (acetaminophen)?
Can a patient with impaired renal function (eGFR of 30) take meloxicam (Mobic)?
What is the initial treatment approach for a patient experiencing a COPD (Chronic Obstructive Pulmonary Disease) exacerbation?
What measles virus genotypes are associated with the development of Subacute Sclerosing Panencephalitis (SSPE) in children and young adults?
When should Fosamax (alendronate) not be used in patients, particularly those with esophageal abnormalities, hypocalcemia, kidney disease, or a history of gastrointestinal disorders?
What are the best Selective Serotonin Reuptake Inhibitors (SSRIs) for a noncompliant adult patient with a history of depression or anxiety who may skip doses frequently?
What is the preferred time to take rivaroxaban (Xarelto) for a patient with a history of cardiovascular issues, such as non-valvular atrial fibrillation, deep vein thrombosis, or pulmonary embolism, and impaired renal function?
What is the appropriate management for a female patient of reproductive age with a diagnosis of atypical squamous cells of undetermined significance (ASC-US) on a Pap test?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question